Tango Therapeutics TNGX Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

46.7%+17.8pp

AmgenAMGN

91.5%-7.7pp

Gilead SciencesGILD

-20.6%-53.8pp

ExelixisEXEL

44.4%+15.4pp

IDEAYA Biosciences, Inc.IDYA

-14.3%-5.0pp

Erasca, Inc.ERAS

-69.9%+77.1pp

FAQ

What is Tango Therapeutics's return on equity?

Tango Therapeutics (TNGX) reported return on equity of -38.4% in Q1 2026.

How has Tango Therapeutics's return on equity changed year-over-year?

Tango Therapeutics's return on equity increased by 37.4% year-over-year, from -61.3% to -38.4%.

What is the long-term trend for Tango Therapeutics's return on equity?

Over 5 years (2020 to 2025), Tango Therapeutics's return on equity has grown at a -27.5% compound annual growth rate (CAGR), from -185.9% to -37.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.